0001193125-18-249783.txt : 20180815 0001193125-18-249783.hdr.sgml : 20180815 20180815162807 ACCESSION NUMBER: 0001193125-18-249783 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 4 CONFORMED PERIOD OF REPORT: 20180815 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20180815 DATE AS OF CHANGE: 20180815 FILER: COMPANY DATA: COMPANY CONFORMED NAME: METLIFE INC CENTRAL INDEX KEY: 0001099219 STANDARD INDUSTRIAL CLASSIFICATION: LIFE INSURANCE [6311] IRS NUMBER: 134075851 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-15787 FILM NUMBER: 181021304 BUSINESS ADDRESS: STREET 1: 200 PARK AVENUE CITY: NEW YORK STATE: NY ZIP: 10166 BUSINESS PHONE: 212-578-5500 MAIL ADDRESS: STREET 1: 200 PARK AVENUE CITY: NEW YORK STATE: NY ZIP: 10166 8-K 1 d571544d8k.htm 8-K 8-K

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported): August 15, 2018

 

 

METLIFE, INC.

(Exact Name of Registrant as Specified in Its Charter)

 

 

 

Delaware   1-15787   13-4075851
(State or Other Jurisdiction
of Incorporation)
  (Commission
File Number)
  (IRS Employer
Identification No.)

 

200 Park Avenue, New York, New York     10166-0188
(Address of Principal Executive Offices)     (Zip Code)

212-578-9500

(Registrant’s Telephone Number, Including Area Code)

N/A

(Former Name or Former Address, if Changed Since Last Report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company  ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

 

 

 


Item 8.01 Other Events.

On August 15, 2018, MetLife, Inc. issued a news release announcing the declaration of (i) a quarterly dividend of $0.25555555 per share on MetLife, Inc.’s floating rate non-cumulative preferred stock, Series A, $25 liquidation preference per share; (ii) a semi-annual dividend of $28.23263888 per share on MetLife, Inc.’s 5.875% fixed-to-floating rate non-cumulative preferred stock, Series D, $1,000 liquidation preference per share; and (iii) a quarterly dividend of $394.53125 per share on MetLife, Inc.’s 5.625% non-cumulative preferred stock, Series E, $25,000 liquidation preference per share, which is $0.39453125 per depositary share, each representing a 1/1,000th interest in a share of Series E Preferred Stock. A copy of the news release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits.

(a) Not applicable.

(b) Not applicable.

(c) Not applicable.

(d) Exhibits

 

99.1    News release of MetLife, Inc., dated August  15, 2018, announcing the declaration of a quarterly dividend on its floating rate non-cumulative preferred stock, Series A; a semi-annual dividend on its 5.875% fixed-to-floating rate non-cumulative preferred stock, Series D; and a quarterly dividend on its 5.625% non-cumulative preferred stock, Series E.


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

METLIFE, INC.
By:    /s/ Jeannette N. Pina
  Name: Jeannette N. Pina
  Title: Vice President and Secretary

Date: August 15, 2018

EX-99.1 2 d571544dex991.htm EX-99.1 EX-99.1

Exhibit 99.1

 

LOGO    LOGO

 

Contacts:        For Media:   Ashia Razzaq
     MetLife
     (212) 578-1538
    
   For Investors:       John Hall
     MetLife
     (212) 578-7888

    MetLife Declares Third Quarter 2018 Preferred Stock Dividends

NEW YORK, Aug 15, 2018-MetLife, Inc. (NYSE: MET) today announced that it has declared the following preferred stock dividends:

 

   

Quarterly dividend of $0.25555555 per share on the company’s floating rate non-cumulative preferred stock, Series A, with a liquidation preference of $25 per share (NYSE: METPrA).

 

   

Initial semi-annual dividend of $28.23263888 per share on the company’s 5.875% fixed-to-floating rate non-cumulative preferred stock, Series D, with a liquidation preference of $1,000 per share.

 

   

Initial quarterly dividend of $394.53125 per share on the company’s 5.625% non-cumulative preferred stock, Series E, with a liquidation preference of $25,000 per share, represented by depositary shares each representing 1/1,000th interest in a share of the preferred stock, holders of which will receive $0.39453125 per depositary share (NYSE: METPrE).

The above dividends will be payable Sept. 17, 2018, to shareholders of record as of Aug. 31, 2018.

###

About MetLife

MetLife, Inc. (NYSE: MET), through its subsidiaries and affiliates (“MetLife”), is one of the world’s leading financial services companies, providing insurance, annuities, employee benefits and asset management to help its individual and institutional customers navigate their changing world. Founded in 1868, MetLife has operations in more than 40 countries and holds leading market positions in the United States, Japan, Latin America, Asia, Europe and the Middle East. For more information, visit www.metlife.com.

Forward-Looking Statements

This news release may contain or incorporate by reference information that includes or is based upon forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements give expectations or forecasts of future events. These statements can be


identified by the fact that they do not relate strictly to historical or current facts. They use words and terms such as “anticipate,” “estimate,” “expect,” “project,” “intend,” “plan,” “believe,” “will,” and other words and terms of similar meaning, or are tied to future periods, in connection with a discussion of future performance. In particular, these include statements relating to future actions, prospective services or products, future performance or results of current and anticipated services or products, sales efforts, expenses, the outcome of contingencies such as legal proceedings, trends in operations and financial results.

Many factors will be important in determining the results of MetLife, Inc., its subsidiaries and affiliates. Forward-looking statements are based on our assumptions and current expectations, which may be inaccurate, and on the current economic environment, which may change. They involve a number of risks and uncertainties that are difficult to predict. Results could differ materially from those expressed or implied in the forward-looking statements. Risks, uncertainties, and other factors that might cause such differences include the risks, uncertainties and other factors identified in MetLife, Inc.’s most recent Annual Report on Form 10-K (the “Annual Report”) filed with the U.S. Securities and Exchange Commission (the “SEC”), any Quarterly Reports on Form 10-Q filed by MetLife, Inc. with the SEC after the date of the Annual Report under the captions “Note Regarding Forward-Looking Statements” and “Risk Factors,” and other filings MetLife, Inc. makes with the SEC. MetLife, Inc. does not undertake any obligation to publicly correct or update any forward-looking statement if MetLife, Inc. later becomes aware that such statement is not likely to be achieved. Please consult any further disclosures MetLife, Inc. makes on related subjects in reports to the SEC.

 

Page 2 of 2

GRAPHIC 3 g571544snap-metlife1.jpg GRAPHIC begin 644 g571544snap-metlife1.jpg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end GRAPHIC 4 g571544snap-metlife2.jpg GRAPHIC begin 644 g571544snap-metlife2.jpg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end